Thrivent Financial for Lutherans’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,137
Closed -$1.6M 2501
2022
Q2
$1.6M Sell
50,137
-3,347
-6% -$107K ﹤0.01% 1376
2022
Q1
$1.85M Sell
53,484
-55
-0.1% -$1.91K ﹤0.01% 1376
2021
Q4
$1.57M Buy
53,539
+272
+0.5% +$7.96K ﹤0.01% 1562
2021
Q3
$1.36M Buy
53,267
+329
+0.6% +$8.38K ﹤0.01% 1637
2021
Q2
$1.85M Buy
52,938
+847
+2% +$29.7K ﹤0.01% 1464
2021
Q1
$2.12M Sell
52,091
-85,437
-62% -$3.48M ﹤0.01% 1380
2020
Q4
$5.96M Buy
137,528
+45,380
+49% +$1.97M 0.01% 801
2020
Q3
$5.08M Buy
92,148
+78,037
+553% +$4.3M 0.01% 788
2020
Q2
$890K Hold
14,111
﹤0.01% 1572
2020
Q1
$720K Buy
+14,111
New +$720K ﹤0.01% 1505
2017
Q2
Sell
-30,400
Closed -$1.12M 2092
2017
Q1
$1.12M Sell
30,400
-21,070
-41% -$776K ﹤0.01% 1102
2016
Q4
$744K Hold
51,470
﹤0.01% 1302
2016
Q3
$1.19M Hold
51,470
0.01% 1065
2016
Q2
$854K Buy
+51,470
New +$854K ﹤0.01% 1170